Back to BBOTView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
7 competitors in Achondroplasia
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
acoramidisPhase 3
Amyloidosis
Acoramidis (AG10)Phase 3
Amyloid Cardiomyopathy, Transthyretin-Related
EncaleretPhase 3
Autosomal Dominant Hypocalcemia (ADH)
Infigratinib is provided as a single dose of minitablets for oral administrationPhase 2
Achondroplasia
Infigratinib 0.016 mg/kgPhase 2
Achondroplasia
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts